CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,022,466 | -25.3% | 5,957,730 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $33,484,180 | +20.2% | 5,571,411 | +16.4% | 0.00% | 0.0% |
| Q3 2022 | $27,854,000 | +6.6% | 4,786,023 | +9.4% | 0.00% | 0.0% |
| Q2 2022 | $26,128,000 | +55.4% | 4,376,439 | +21.6% | 0.00% | – |
| Q1 2022 | $16,810,000 | +101.1% | 3,599,415 | +6.8% | 0.00% | – |
| Q4 2021 | $8,359,000 | -22.9% | 3,370,815 | -8.3% | 0.00% | – |
| Q3 2021 | $10,844,000 | +18.3% | 3,676,004 | +0.3% | 0.00% | – |
| Q2 2021 | $9,165,000 | +3.4% | 3,666,204 | +20.4% | 0.00% | – |
| Q1 2021 | $8,862,000 | -7.1% | 3,045,312 | +2.8% | 0.00% | – |
| Q4 2020 | $9,538,000 | +56.4% | 2,962,312 | +4.4% | 0.00% | – |
| Q3 2020 | $6,098,000 | +144.7% | 2,836,130 | +32.0% | 0.00% | – |
| Q2 2020 | $2,492,000 | +26.0% | 2,149,048 | 0.0% | 0.00% | – |
| Q1 2020 | $1,977,000 | -17.5% | 2,149,048 | +41.8% | 0.00% | – |
| Q4 2019 | $2,395,000 | +115.2% | 1,515,674 | +13.4% | 0.00% | – |
| Q3 2019 | $1,113,000 | +22.7% | 1,336,805 | +26.6% | 0.00% | – |
| Q2 2019 | $907,000 | -37.9% | 1,055,954 | -29.8% | 0.00% | – |
| Q1 2019 | $1,460,000 | +32.5% | 1,504,296 | +0.1% | 0.00% | – |
| Q4 2018 | $1,102,000 | -78.6% | 1,502,494 | -37.1% | 0.00% | – |
| Q3 2018 | $5,158,000 | -56.6% | 2,387,830 | -0.0% | 0.00% | – |
| Q2 2018 | $11,896,000 | +41.7% | 2,388,851 | +11.0% | 0.00% | – |
| Q1 2018 | $8,396,000 | +268.2% | 2,152,864 | +153.0% | 0.00% | – |
| Q4 2017 | $2,280,000 | -33.6% | 850,881 | -20.9% | 0.00% | – |
| Q3 2017 | $3,433,000 | +37.7% | 1,076,049 | +42.8% | 0.00% | – |
| Q2 2017 | $2,494,000 | -26.9% | 753,379 | -7.3% | 0.00% | – |
| Q1 2017 | $3,412,000 | – | 812,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |